| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |